Featured Research

from universities, journals, and other organizations

Closer to understand autoimmune diseases

Date:
March 6, 2012
Source:
University of Alberta Faculty of Medicine & Dentistry
Summary:
Understanding why immune cells, called T-cells, attack the body is vital in the war against autoimmune diseases like diabetes. Researchers are a step closer to understanding why the body's T-cells sometimes attack healthy cells causing autoimmune diseases.

University of Alberta researcherTroy Baldwin is a step closer to understanding why the body's immune cells, called T-cells, sometimes attack perfectly healthy cells causing autoimmune diseases like diabetes.

Baldwin, a researcher in the Department of Medical Microbiology and Immunology, and graduate student Alex Suen looked at a specific molecule, known as BIM, which is vital in regulating T-cell death. He explained that when BIM was removed from auto-reactive T-cells, rather than being killed off and eliminated from the blood, the T-cells actually survived and were rendered inactive.

Baldwin, whose study was published in the Proceedings of the National Academy of Sciences, says his research also found there is a mechanism that controls T-cells beyond the reach of BIM. Looking specifically at the T-cells that target the pancreas, which is a cause of diabetes, Baldwin explains that the auto-reactive T-cells that survived in the absence of BIM weren't able to kill the insulin-producing cells in the pancreas.

"Our future work is going to look at the mechanisms controlling these cells," said Baldwin. "Even though T-cells are present in the body and should be able to target, in this case, the pancreas and cause diabetes, they don't."

Baldwin says understanding why these cells don't target the pancreas and why they are inactive could lead to new therapies to control auto-reactive T-cells and help people with autoimmune diseases.

"Something is telling them not to become active," said Baldwin. "If we can figure out what that something is we could then potentially use that information to try and either suppress cells that would normally become activated and cause autoimmunity or, vice versa, we could now take T-cells that are not active and make them more active."

Baldwin says cancer therapies, for example, are one instance where physicians want to boost T-cell response. "If we turn that suppressive mechanism off, then perhaps we can make a cell that wouldn't normally respond, responsive," he says.

The next step will be to begin searching for the other mechanisms that regulate T-cells.

"First we want to try and understand if there are other cells that are controlling this auto-reactive population, or if it is something in the cells themselves that is preventing them from being active," said Baldwin.

"If we can break those control mechanisms, then we can understand how autoimmune diseases can progress," added Suen. "That will give us an idea of what to target to generate therapies to either try to prevent breaking that control or enforcing that control more strictly."


Story Source:

The above story is based on materials provided by University of Alberta Faculty of Medicine & Dentistry. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. Y. W. Suen, T. A. Baldwin. Proapoptotic protein Bim is differentially required during thymic clonal deletion to ubiquitous versus tissue-restricted antigens. Proceedings of the National Academy of Sciences, 2012; 109 (3): 893 DOI: 10.1073/pnas.1114834109

Cite This Page:

University of Alberta Faculty of Medicine & Dentistry. "Closer to understand autoimmune diseases." ScienceDaily. ScienceDaily, 6 March 2012. <www.sciencedaily.com/releases/2012/03/120306131900.htm>.
University of Alberta Faculty of Medicine & Dentistry. (2012, March 6). Closer to understand autoimmune diseases. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/03/120306131900.htm
University of Alberta Faculty of Medicine & Dentistry. "Closer to understand autoimmune diseases." ScienceDaily. www.sciencedaily.com/releases/2012/03/120306131900.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins